Summit Therapeutics Inc.

24.56
-1.57 (-6.01%)
At close: Apr 15, 2025, 3:59 PM
24.26
-1.22%
Pre-market: Apr 16, 2025, 08:29 AM EDT

Summit Therapeutics Stock Forecast

Stock Price Forecast

The 11 analysts with 12-month price forecasts for SMMT stock have an median target of 33.5, with a low estimate of 30 and a high estimate of 44. The median target predicts an increase of 36.40% from the current stock price of 24.56.

Target Low Average Median High
Price $30 $35.1 $33.5 $44
Change 22.15% 42.92% 36.40% 79.15%

Latest Analyst Insight Report

HC Wainwright & Co. maintains a Buy rating for Sum... Unlock content with Pro Subscription

Updated Feb 25, 2025

Rating Oct 24Nov 24Dec 24Jan 25Feb 25Mar 25
Strong Buy 000001
Buy 212232
Hold 000000
Sell 000000
Strong Sell 000000
Total 2 1 2 2 3 3

Financial Forecast this Year

Revenue This Year
34.46M
from 0
Increased by -%
Revenue Next Year
14.01M
from 34.46M
Increased by -59.3%
EPS This Year
-0.35
from -0.31
Increased by -12.9%
EPS Next Year
-0.49
from -0.35
Increased by -40%